| Abstrakt: |
PENSACOLA, Fla., Sept. 16, 2021 /PRNewswire-PRWeb/ -- Regenative Labs, the established leader in the connective tissue allograft space, today launched AmnioText™ Dual-Layer Patch for wounds. AmnioText is the company's first product to offer private practices, hospitals and wound care centers a sterile, dehydrated amniotic membrane allograft to cover and protect a patient's wounded tissues. The Regenative Labs current suite of products are regulated by the FDA under 21 CFR part 1271 section 361, are minimally manipulated and for homologous use only. [ABSTRACT FROM PUBLISHER] |
